Two-stage total hip arthroplasty: How often does it control methicillin-resistant infection?

Clinical Orthopaedics and Related Research

Volumn 469, Issue 4, 2011, Pages 1009-1015

  Leung, Fay ^a   Richards, Corey J ^b   Garbuz, Donald S ^a   Masri, Bassam A ^a   Duncan, Clive P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Hull Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PALACOS; TOBRAMYCIN; VANCOMYCIN; BONE CEMENT;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION CONTROL; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS INFECTION; RECURRENT INFECTION; REOPERATION; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; TWO STAGE TOTAL HIP ARTHROPLASTY; ARTICLE; CANADA; CHI SQUARE DISTRIBUTION; CONVALESCENCE; HIP; HIP ARTHROPLASTY; HIP PROSTHESIS; INFECTION; INSTRUMENTATION; JOINT CHARACTERISTICS AND FUNCTIONS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PROSTHESIS; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; BRITISH COLUMBIA; CHI-SQUARE DISTRIBUTION; FEMALE; HIP JOINT; HIP PROSTHESIS; HUMANS; INFECTION CONTROL; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PATIENT SATISFACTION; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; QUALITY OF LIFE; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955808779     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-010-1725-6     Document Type: Conference Paper

References (28)

1. Amstutz HC, Thomas BJ, Jinnah R, Kim W, Grogan T, Yale C. Treatment of primary osteoarthritis of the hip: a comparison of total joint and surface replacement arthroplasty. J Bone Joint Surg Am. 1984;66:228-241. (Pubitemid 14150389)
2. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840. (Pubitemid 19037656)
3. Biring GS, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg Br. 2009;91:1431-1437.
4. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63:342-353. (Pubitemid 11039510)
5. Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip: a minimum 10-year followup study. Clin Orthop Relat Res. 1999;369:139-143.
6. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am. 1998;80:1306-1313. (Pubitemid 28443354)
7. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br. 1996;78:185-190. (Pubitemid 26096988)
8. Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip. Orthop Clin North Am. 1993;24:751-759. (Pubitemid 23321299)
9. Garvin KL, Hanssen AD. Infection after total hip arthroplasty: past, present, and future. J Bone Joint Surg Am. 1995;77:1576-1588.
10. Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty. 1988;3:109-116.
11. Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35-39. (Pubitemid 39506148)
12. Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13:22-28. (Pubitemid 28082632)
13. Kantor GS, Osterkamp JA, Dorr LD, Fischer D, Perry J, Conaty JP. Resection arthroplasty following infected total hip replacement arthroplasty. J Arthroplasty. 1986;1:83-89. (Pubitemid 17199789)
14. Katz JN, Phillips CB, Baron JA, Fossel AH, Mahomed NN, Barrett J, Lingard EA, Harris WH, Poss R, Lew RA, Guadagnoli E, Wright EA, Losina E. Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum. 2003;48:560-568. (Pubitemid 36278026)
15. Kilgus DJ, Howe DJ, Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res. 2002;404:116-124. (Pubitemid 35351060)
16. Kostuik J, Alexander D. Arthrodesis for failed arthroplasty of the hip. Clin Orthop Relat Res. 1984;188:173-182. (Pubitemid 14029170)
17. Lieberman JR, Callaway GH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205-212. (Pubitemid 24119275)
18. Lim SJ, Park JC, Moon YW, Park YS. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J Arthroplasty. 2009;24:1264-1269.
19. Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP. Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007;22:72-78. (Pubitemid 46014043)
20. Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res. 2009;467:1732-1739.
21. Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother. 2006;50:55-61. (Pubitemid 43042902)
22. Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res. 2007;461:48-53. (Pubitemid 47344093)
23. Shams WE, Rapp RP. Methicillin-resistant staphylococcal infections: an important consideration for orthopedic surgeons. Orthopedics. 2004;27:565-568. (Pubitemid 38923406)
24. Toulson C, Walcott-Sapp S, Hur J, Salvati E, Bostrom M, Brause B, Westrich GH. Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol: update on 'our institution's' experience from 1989 to 2003. J Arthroplasty. 2009;24:1051-1060.
25. Volin SJ, Hinrichs SH, Garvin KL. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res. 2004;427:94-100. (Pubitemid 39362837)
26. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
27. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis. 1992;14:1251-1253.
28. Younger AS, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty. 1997;12:615-623. (Pubitemid 27427939)